A61K 38/085
Angiotensins
Official title: {Angiotensins}
A61K38/085 (Angiotensins) appears on 143 US grants and 232 published applications in this corpus.
Search patents in A61K- Granted patents
- 143
- Published applications
- 232
- Assignees
- 99
- Inventors
- 291
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 0 |
| 2002 | 7 | 3 |
| 2003 | 4 | 13 |
| 2004 | 3 | 6 |
| 2005 | 2 | 7 |
| 2006 | 3 | 4 |
| 2007 | 2 | 2 |
| 2008 | 2 | 11 |
| 2009 | 1 | 8 |
| 2010 | 8 | 12 |
| 2011 | 5 | 17 |
| 2012 | 9 | 5 |
| 2013 | 10 | 11 |
| 2014 | 5 | 9 |
| 2015 | 7 | 13 |
| 2016 | 6 | 13 |
| 2017 | 6 | 10 |
| 2018 | 5 | 12 |
| 2019 | 8 | 13 |
| 2020 | 6 | 12 |
| 2021 | 8 | 12 |
| 2022 | 3 | 11 |
| 2023 | 2 | 9 |
| 2024 | 4 | 7 |
| 2025 | 3 | 8 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method to increase systemic blood pressure in shock21 Jul 2026US 12,685,757 B2Georgetown University
- Methods for decreasing injuries associated with intraoperative hypotension17 Mar 2026US 12,576,058 B2The United States Government as represented by the Department of Veterans Affairs
- Micelles and vesicles for the delivery of glycopeptides25 Nov 2025US 12,478,585 B2Arizona Board of Regents on Behalf of the University of Arizona
- Ang (1-7) derivative oligopeptides for the treatment of pain7 Oct 2025US 12,433,932 B2Arizona Board of Regents on Behalf of the University of Arizona
- Methods and agents that stimulate mitochondrial turnover for treating disease1 Jul 2025US 12,343,331 B2Capacity Bio, Inc.
- Methods for decreasing injuries associated with intraoperative hypotension3 Sep 2026US 2026/0256725 A1ResQ Pharma, Inc.
- Treatment for auditory disorders6 Aug 2026US 2026/0224535 A1
- Gamma-secretase inhibitors for use in the treatment of inherited epidermolysis bullosa5 Mar 2026US 2026/0060960 A1
- Methods and agents that stimulate mitochondrial turnover for treating disease5 Mar 2026US 2026/0060962 A1Capacity Bio, Inc.
- Extended-release injectable gel formulations containing angiotensin-(1-7) oligopeptides or variants thereof30 Oct 2025US 2025/0332213 A1ProNeurogen, Inc.
Most cited
By later US patents
- Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation139US 6,335,195 B12002
- Method for promoting mesenchymal stem and lineage-specific cell proliferation122US 6,248,587 B1University of Southern Cailfornia · 2001
- Methods to increase blood flow to ischemic tissue85US 6,177,407 B1University of Southern California · 2001
- Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase63US 7,899,527 B2Palo Alto Investors · 2011
- Use of angiotensin III and analogs thereof in tissue repair55US 5,629,292 AUniversity of Southern California · 1997